Invitation-only event to form collaborations between leading mHealth innovators and 11 of the largest healthcare corporations to develop meaningful commercial projects
17 September 2014 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, has today announced that it is presenting on its role as a key innovator in the mHealth market at the HealthXL conference taken place in San Francisco, USA. all present at the event. The company was one of just 20 chosen from a shortlist of 150 companies selected to speak at the event. The audience of HealthXL strategic partners includes prominent commercial stakeholders in the healthcare sector including BUPA, Cleveland Clinic, GSK, IBM, ICON Plc, Janssen Healthcare Innovation, Linde Health, Novartis, Partners HealthCare, ResMed and Silicon Valley Bank.
HealthXL is designed to link together leading innovators developing mHealth solutions and healthcare companies seeking to develop meaningful commercial projects. The central goal of connecting prominent brands with cutting edge technology providers is to drive global innovation in mHealth, with the specific aim of improving the provision of healthcare to patients worldwide.
Commenting on Exco InTouch’s selection and participation in the event, Tim Davis, CEO and Founder remarked: “We are delighted to have the opportunity to present our experience and expertise as a company at the forefront of mHealth innovation. Indeed, we look forward to discussing the full impact that mHealth services, uniquely tailored to the primary issues and challenges facing patient populations, can offer to address the rising cost burden of chronic health conditions.”
He continued: “We are always keen to forge ever stronger links with leading companies in the healthcare sector, including HealthXL partners, to further expand the use and benefits of our innovative mHealth solutions throughout the healthcare market.”
About Exco InTouch
Exco InTouch is leading provider of digital patient engagement and data capture solutions to support Clinical, Late Phase and mHealth programs for leading healthcare and biopharmaceutical companies. Placing the patient at its heart, our proven technology can be employed on any device, empowering the patient to be more involved in their healthcare and ultimately leading to better health outcomes. Using a combination of patented software and services our technology can be scaled up to match clients’ requirements and our trusted, low risk applications mean that you can be confident that your data is secure and protected, in line with global regulatory and data protection requirements.
Our solutions capitalize upon global mobile device and internet usage, using a device independent approach enabling involvement which integrates into daily life - resulting in motivated and compliant patients across a wealth of therapeutic, demographic and geographic programs in clinical and commercial settings. Since 2004, Exco InTouch have engaged with over 900,000 subjects across 85 countries, over 15,000 hospitals and clinics, in 70 languages and 16 of the top 20 pharmaceutical companies have deployed our technology.
For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on +44 (0) 207 203 6740 or e-mail t.jervis@defacto.com.
Help employers find you! Check out all the jobs and post your resume.
